Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;84(4):1100-1103.
doi: 10.1016/j.jaad.2020.12.065. Epub 2021 Jan 19.

The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers

Justin W Marson  1 , Brittany S Maner  2 , Tanner P Harding  3 , John Meisenheimer VII  4 , James A Solomon  2 , Matt Leavitt  5 , Nicole J Levin  6 , Robert Dellavalle  7 , Ian Brooks  8 , Darrell S Rigel  9
Affiliations

The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers

Justin W Marson et al. J Am Acad Dermatol. 2021 Apr.
No abstract available

Keywords: COVID-19; basal cell carcinoma; cutaneous melanoma; cutaneous squamous cell carcinoma; diagnostic delay; nonmelanoma skin cancer.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest None disclosed.

Figures

Fig 1
Fig 1
Mean difference in skin cancer diagnoses owing to COVID-19. Across the different types of skin cancers, there was a significant decrease in average number of diagnoses from the initial to peak COVID-19 pandemic (March to May 2020) compared with pre–COVID-19 (before March 2020) and the immediate COVID-19 recovery period (June to August 2020). BCC, Basal cell carcinoma; CI, confidence interval; COVID-19, coronavirus disease 2019; cSCC, cutaneous squamous cell carcinoma. ∗Analysis of variance with post hoc Tukey-Kramer, P < .01.
See this image and copyright information in PMC

References

    1. Litchman G.H., Rigel D.S. The immediate impact of COVID-19 on US dermatology practices. J Am Acad Dermatol. 2020;83(2):685–686. - PMC - PubMed
    1. Litchman G.H., Marson J.W., Rigel D.S. The continuing impact of COVID-19 on dermatology practice: office workflow, economics and future implications. J Am Acad Dermatol. 2021;84(2):576–579. - PMC - PubMed
    1. COVID-19 resources. National Comprehensive Cancer Network. https://www.nccn.org/covid-19/ Accessed September 25, 2020. Available at:
    1. Tejera-Vaquerizo A., Nagore E. Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model. J Eur Acad Dermatol Venereol. 2020;34(8):e351–e353. - PMC - PubMed
    1. Pacifico M.D., Pearl R.A., Grover R. The UK government two-week rule and its impact on melanoma prognosis: an evidence-based study. Ann R Coll Surg Engl. 2007;89:609–615. - PMC - PubMed